Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
, Mary Wikswo, Leslie Barclay, Eric Brandt, William Storm, Ellen Salehi, Traci DeSalvo, Tim Davis, Amy Saupe, Ginette Dobbins, Hillary A. Booth, Christianne Biggs, Katie Garman, Amy M. Woron, Umesh D. Parashar, Jan Vinjé, and Aron J. Hall
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E. Leshem, M. Wikswo, L. Barclay, U.D. Parashar, J. Vinjé, A.J. Hall); Ohio Department of Health, Columbus, Ohio, USA (E. Brandt, W. Storm, E. Salehi); Wisconsin Department of Health Services, Madison, Wisconsin, USA (T. DeSalvo); Wisconsin State Laboratory of Hygiene, Madison (T. Davis); Minnesota Department of Health, St. Paul, Minnesota, USA (A. Saupe, G. Dobbins); Oregon Public Health Division, Portland, Oregon, USA (H.A. Booth, C. Biggs); Tennessee Department of Health, Nashville, Tennessee, USA (K. Garman, A.M. Woron)
Figure 1. . . . . Number of suspected and confirmed norovirus gastroenteritis outbreaks by week of illness onset: Minnesota, Ohio, Oregon, Tennessee, and Wisconsin, August 1, 2010–April 16, 2013 (no. outbreaks = 1,605).
Page created: July 23, 2013
Page updated: July 23, 2013
Page reviewed: July 23, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.